New Scrutiny of Drugs in Vioxx's Family
9826
Millions of patients and billions of dollars in sales could be affected by knowing whether the risks to the heart posed by Merck's Vioxx extend to other COX-2 inhibitors.
62492
Merck&#39;s recall of its arthritis pain drug, Vioxx, because of elevated risks of heart attack and stroke has obscured another important issue that Congress, in investigating the matter, must face squarely and deal with: What happens when pharmaceutical
668955
A new study linking high doses of Vioxx to an increased risk of heart attacks and sudden cardiac deaths has re-ignited a running debate about the safety of the arthritis drug.
476114
WASHINGTON - The FDA scientist who studied the safety of the recalled painkiller Vioxx delivered a bombshell Thursday, naming five more drugs he believes could be dangerous.
63006
When Dr. Sherwin Siff got the news three months ago that the popular painkiller Vioxx was being pulled from the market, he had a good idea its cousins, Celebrex and Bextra, would face problems, too.
365737
The safety of Merck&#39;s (MRK:NYSE - news - research) Vioxx has been questioned again with the posting of an internal Food and Drug Administration study on the agency&#39;s website.
652888
The European Commission has ordered a full-scale probe into the safety of five remaining Cox-2 arthritis drugs, following last month's worldwide withdrawal of Merck & Co Inc.'s Vioxx.
54816
Medicines used by millions of  Americans to relieve aches and pains will come under intense  scrutiny starting Wednesday as U.S. scientists scour dozens of  studies to determine if the drugs risk damaging the heart like  Merck & Co. Inc.'s MRK.N withdrawn arthritis pill Vioxx.
721591
Merck &amp; Co., Inc., knew of problems with its blockbuster painkiller Vioxx long before the drug was pulled from the market in September due to newer studies that linked the medication to an increased risk of heart attack and stroke, the Wall Street Journal
497670
Oct. 11 issue - Last week Merck pulled its blockbuster arthritis-and-pain-relief drug Vioxx from the market. This week the 1.27 million Americans who were taking it are wondering what to do.
34608
GAITHERSBURG, Md.  - U.S. scientific advisers  began hearing evidence on Wednesday about the benefits and  risks of pain killers taken by millions of Americans as  regulators weigh moves following Merck & Co. Inc.'s recall of  its arthritis pill Vioxx.
300815
An East Tennessee man claims the arthritis drug Vioxx killed his wife, seven weeks ago. The drug was pulled from store shelves this fall after a report proved Vioxx doubled the risk of heart attacks and strokes in some patients.
566881
A paper published Tuesday suggests that Vioxx posed heart risks that a similar drug, Celebrex, does not.
573622
FRIDAY, Oct. 8 (HealthDayNews) -- A week after drug giant Merck & Co. withdrew its arthritis drug Vioxx from the market, doubts are being raised about the safety of the two other approved medications in this class, Bextra and Celebrex.
695440
Now that Merck has removed its arthritis painkiller Vioxx from the market after tests found it increased the risk of heart attacks and strokes, its rival Pfizer is taking a surprising stance.
144122
Scientists uncover why some arthritis drugs such as Vioxx can cause heart attacks and strokes.
108301
Federal prosecutors and the S.E.C. are investigating Merck in connection with its recalled pain reliever, Vioxx.